Rui-Hong Wang

4.2k total citations · 1 hit paper
16 papers, 3.4k citations indexed

About

Rui-Hong Wang is a scholar working on Molecular Biology, Geriatrics and Gerontology and Physiology. According to data from OpenAlex, Rui-Hong Wang has authored 16 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Geriatrics and Gerontology and 4 papers in Physiology. Recurrent topics in Rui-Hong Wang's work include Sirtuins and Resveratrol in Medicine (8 papers), Adipose Tissue and Metabolism (4 papers) and CRISPR and Genetic Engineering (3 papers). Rui-Hong Wang is often cited by papers focused on Sirtuins and Resveratrol in Medicine (8 papers), Adipose Tissue and Metabolism (4 papers) and CRISPR and Genetic Engineering (3 papers). Rui-Hong Wang collaborates with scholars based in United States, France and Italy. Rui-Hong Wang's co-authors include Chu‐Xia Deng, Xiaoling Xu, Cuiying Xiao, Hyun‐Seok Kim, Zheng Yin, Athanassios Vassilopoulos, Tyler Lahusen, Hongtao Yu, Cuiling Li and Xin Wei Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Rui-Hong Wang

16 papers receiving 3.3k citations

Hit Papers

Impaired DNA Damage Respo... 2008 2026 2014 2020 2008 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui-Hong Wang United States 15 1.6k 1.5k 869 590 496 16 3.4k
Daniel Herranz United States 24 1.8k 1.2× 1.3k 0.9× 891 1.0× 1.3k 2.2× 581 1.2× 36 3.9k
Jianyuan Luo China 19 2.3k 1.5× 1.4k 1.0× 718 0.8× 585 1.0× 865 1.7× 30 3.6k
Gaëlle Laurent United States 13 1.3k 0.8× 501 0.3× 358 0.4× 551 0.9× 207 0.4× 15 2.0k
Brooke M. Emerling United States 20 1.4k 0.9× 238 0.2× 312 0.4× 332 0.6× 248 0.5× 36 2.1k
Jianyuan Luo China 27 1.9k 1.2× 1.2k 0.8× 737 0.8× 717 1.2× 668 1.3× 54 3.4k
Hitomi Matsuzaki Japan 18 2.1k 1.3× 465 0.3× 397 0.5× 562 1.0× 389 0.8× 37 3.1k
Susana Velasco-Miguel United States 17 1.8k 1.2× 517 0.4× 395 0.5× 578 1.0× 845 1.7× 22 3.0k
Beixue Gao United States 31 1.5k 1.0× 452 0.3× 617 0.7× 255 0.4× 382 0.8× 42 2.6k
Hiroaki Daitoku Japan 22 3.0k 1.9× 650 0.4× 572 0.7× 768 1.3× 534 1.1× 46 4.1k
Christoph Westphal United States 21 1.2k 0.8× 831 0.6× 422 0.5× 567 1.0× 483 1.0× 24 2.3k

Countries citing papers authored by Rui-Hong Wang

Since Specialization
Citations

This map shows the geographic impact of Rui-Hong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui-Hong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui-Hong Wang more than expected).

Fields of papers citing papers by Rui-Hong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui-Hong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui-Hong Wang. The network helps show where Rui-Hong Wang may publish in the future.

Co-authorship network of co-authors of Rui-Hong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Rui-Hong Wang. A scholar is included among the top collaborators of Rui-Hong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui-Hong Wang. Rui-Hong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Choi, Su‐Mi, Yonghak Kim, Joong Sup Shim, et al.. (2013). Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology. 57(6). 2458–2468. 179 indexed citations
3.
Xiao, Cuiying, Rui-Hong Wang, Tyler Lahusen, et al.. (2012). Progression of Chronic Liver Inflammation and Fibrosis Driven by Activation of c-JUN Signaling in Sirt6 Mutant Mice. Journal of Biological Chemistry. 287(50). 41903–41913. 135 indexed citations
4.
Kim, Hyun‐Seok, Athanassios Vassilopoulos, Rui-Hong Wang, et al.. (2011). SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity. Cancer Cell. 20(4). 487–499. 418 indexed citations
5.
Kim, Hyun‐Seok, Cuiying Xiao, Rui-Hong Wang, et al.. (2010). Hepatic-Specific Disruption of SIRT6 in Mice Results in Fatty Liver Formation Due to Enhanced Glycolysis and Triglyceride Synthesis. Cell Metabolism. 12(3). 224–236. 410 indexed citations
6.
Xiao, Cuiying, Hyun‐Seok Kim, Tyler Lahusen, et al.. (2010). SIRT6 Deficiency Results in Severe Hypoglycemia by Enhancing Both Basal and Insulin-stimulated Glucose Uptake in Mice. Journal of Biological Chemistry. 285(47). 36776–36784. 165 indexed citations
7.
Liu, Meilian, Anping Wang, Lijun Zhou, et al.. (2010). Resveratrol Inhibits mTOR Signaling by Promoting the Interaction between mTOR and DEPTOR. Journal of Biological Chemistry. 285(47). 36387–36394. 153 indexed citations
8.
Shukla, Vivek, Xavier Coumoul, Tyler Lahusen, et al.. (2010). BRCA1 affects global DNA methylation through regulation of DNMT1. Cell Research. 20(11). 1201–1215. 77 indexed citations
9.
Wang, Rui-Hong, Zheng Yin, Hyun‐Seok Kim, et al.. (2008). Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis. Molecular Cell. 32(1). 11–20. 283 indexed citations
10.
Wang, Rui-Hong, Kundan Sengupta, Cuiling Li, et al.. (2008). Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice. Cancer Cell. 14(4). 312–323. 634 indexed citations breakdown →
11.
Mantel, Charlie, Rui-Hong Wang, Chu‐Xia Deng, & Hal E. Broxmeyer. (2008). Sirt1, Notch and stem cell "age asymmetry". Cell Cycle. 7(18). 2821–2825. 8 indexed citations
12.
Vassilopoulos, Athanassios, Rui-Hong Wang, Constantinos Petrovas, et al.. (2008). Identification and characterization of cancer initiating cells from BRCA1 related mammary tumors using markers for normal mammary stem cells. International Journal of Biological Sciences. 4(3). 133–142. 60 indexed citations
13.
Shukla, Vivek, Xavier Coumoul, Rui-Hong Wang, Hyun‐Seok Kim, & Chu‐Xia Deng. (2007). RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis. Nature Genetics. 39(9). 1145–1150. 158 indexed citations
14.
Shukla, Vivek, Xavier Coumoul, Liu Cao, et al.. (2006). Absence of the Full-Length Breast Cancer–Associated Gene-1 Leads to Increased Expression of Insulin-Like Growth Factor Signaling Axis Members. Cancer Research. 66(14). 7151–7157. 36 indexed citations
15.
Wang, Rui-Hong, Cuiling Li, Xiaoling Xu, et al.. (2005). A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metabolism. 2(6). 399–409. 496 indexed citations
16.
Wang, Rui-Hong, Hongtao Yu, & Chu‐Xia Deng. (2004). A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint. Proceedings of the National Academy of Sciences. 101(49). 17108–17113. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026